# Apnimed (APMD) — News

APMD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/apmd/news

## Recent headlines

- [Apnimed indicated to open at $22 per share, IPO price $16](https://www.ainvest.com/news/apnimed-open-22-share-ipo-price-16-2607) — AInvest Wire, Jul 31, 2026
  Apnimed, a pharmaceutical company focused on developing oral treatments for obstructive sleep apnea and related disorders, has drawn attention in the financial markets following reports that its shares opened at $22 apiece in its initial public offering (IPO), exceeding the initial IPO price of $16…
- [APNimed is said to allocate 80% of IPO shares to 10 investors](https://www.ainvest.com/news/apnimed-allocate-80-ipo-shares-10-investors-2607) — AInvest Wire, Jul 31, 2026
  Apnimed Inc., a clinical-stage biopharmaceutical company focused on developing oral treatments for obstructive sleep apnea, has drawn significant investor interest ahead of its anticipated U.S. initial public offering (IPO). According to recent regulatory filings, the company plans to allocate 80%…
- [Apnimed prices upsized IPO of 12M shares at $16.00 each](https://www.ainvest.com/news/apnimed-prices-upsized-ipo-12m-shares-16-00-2607) — AInvest Wire, Jul 31, 2026
- [Apnimed is said to guide IPO pricing to top half of range](https://www.ainvest.com/news/apnimed-guide-ipo-pricing-top-range-2607) — AInvest Wire, Jul 30, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).